Chargement en cours...
In silico identification of EGFR-T790M inhibitors with novel scaffolds: start with extraction of common features
BACKGROUND: Epidermal growth factor receptor (EGFR) is an attractive therapeutic target for a number of human tumors including non-small cell lung cancer (NSCLC). Most patients with NSCLC and somatic mutations have shown a dramatic initial clinical response to reversible EGFR inhibitors. The clinica...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3748928/ https://ncbi.nlm.nih.gov/pubmed/23990708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S41305 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|